Does Aetna Cover ADHD Treatment in Hawaii? A 2026 Guide

Last updated: July 16, 2026

Key takeaway: Aetna health plans in Hawaii may cover ADHD evaluation, medication management, and therapy, though coverage details vary by plan type and employer. Aetna uses CVS Caremark as its pharmacy benefit manager (PBM) for most commercial plans in Hawaii. Stimulant medications such as Adderall and Vyvanse are Schedule II controlled substances — Hawaii’s Electronic Prescribing for Controlled Substances (EPCS) law (HRS § 329-38.5) applies. Non-stimulant medications such as Strattera (atomoxetine) are non-scheduled and are not subject to EPCS. Always verify your specific benefits before booking an appointment.

Does Aetna Cover ADHD Treatment in Hawaii?

Aetna offers individual, family, and employer-sponsored health plans across Hawaii. Most Aetna commercial plans in Hawaii cover ADHD diagnosis and treatment as a mental health benefit under the Mental Health Parity and Addiction Equity Act (MHPAEA) and Hawaii’s own parity statute, Haw. Rev. Stat. § 431M-1 et seq. Coverage typically includes psychiatric evaluation, medication management, therapy, and telehealth services, though the extent of coverage depends on your specific plan design, deductible, and copay structure.

Aetna processes pharmacy benefits through CVS Caremark for most Hawaii commercial members. This means your ADHD prescriptions — whether stimulants or non-stimulants — are adjudicated under the CVS Caremark commercial formulary.

See If Your Aetna Plan May Cover ADHD Treatment →

Aetna CVS Caremark ADHD Formulary (Hawaii, 2026)

The table below reflects the CVS Caremark commercial formulary commonly used by Aetna Hawaii members. Tier placement and prior authorization (PA) requirements may vary by your specific plan. Always verify coverage using your Aetna member portal or by calling the number on your insurance card.

Formulary information is based on the CVS Caremark commercial formulary as of 2026. Your specific Aetna plan may differ. Verify at aetna.com or call Aetna member services at 1-800-872-3862.

Prior Authorization for ADHD Medications Under Aetna

Aetna may require prior authorization (PA) for certain ADHD medications — particularly brand-name stimulants and some non-stimulants. PA requests are typically submitted by your prescribing provider through Availity (availity.com) or via the Aetna provider portal. CVS Caremark pharmacy PA requests can also be initiated through the CVS Caremark provider portal.

Common PA criteria for ADHD medications under Aetna/CVS Caremark may include:

• Confirmed ADHD diagnosis documented in the medical record
• Step therapy — trial of a preferred generic stimulant before brand approval may be required
• Age criteria — some plans apply different criteria for pediatric vs. adult members
• Quantity limits — stimulant prescriptions often carry monthly quantity limits
• Reauthorization — PA approvals typically expire annually and require renewal

Standard PA decisions are generally made within 2–3 business days; urgent requests may be processed within 24–72 hours. If your PA is denied, you have the right to appeal — contact Aetna member services at 1-800-872-3862 for assistance with the appeals process.

Hawaii EPCS Law and ADHD Medications

Hawaii’s Electronic Prescribing for Controlled Substances (EPCS) law — codified at HRS § 329-38.5 — requires electronic prescribing for Schedule II controlled substances. This law directly affects ADHD stimulant prescribing in Hawaii.

Stimulants (Schedule II) — EPCS Required

The following commonly prescribed ADHD stimulants are Schedule II controlled substances under Hawaii law and require electronic prescribing under HRS § 329-38.5:

• Amphetamine salts (Adderall, Adderall XR, and generics)
• Methylphenidate (Ritalin, Concerta, and generics)
• Lisdexamfetamine (Vyvanse and generic)
• Dextroamphetamine (Dexedrine and generics)
• Mixed amphetamine salts

All Klarity Health providers operating in Hawaii are EPCS-compliant and can electronically prescribe Schedule II stimulants where clinically appropriate and legally permissible.

Non-Stimulants (Non-Scheduled) — EPCS Inapplicable

Non-stimulant ADHD medications — atomoxetine (Strattera), guanfacine ER (Intuniv), clonidine ER (Kapvay), and viloxazine (Qelbree) — are non-scheduled medications. Hawaii’s EPCS mandate under HRS § 329-38.5 is entirely inapplicable to these medications. Providers may prescribe non-stimulants using standard electronic or paper prescribing methods.

Note: Hawaii’s EPCS law covers Schedule II substances only — unlike West Virginia’s § 60A-4-403a, which extends EPCS requirements to all controlled substance schedules. This distinction is relevant for providers licensed in multiple states.

Hawaii Mental Health Parity Law

Hawaii’s mental health parity statute — Haw. Rev. Stat. § 431M-1 et seq. — requires state-regulated commercial insurance plans to provide mental health and substance use disorder benefits that are no more restrictive than medical/surgical benefits. ADHD is recognized as a mental health condition covered under parity protections in Hawaii.

Under § 431M-1, Aetna state-regulated commercial plans in Hawaii may not:

• Apply higher copays or deductibles for ADHD treatment than for comparable medical conditions
• Impose stricter visit limits on ADHD therapy than on medical/surgical therapy
• Apply more burdensome PA requirements for ADHD medications than for equivalent medical medications

Important ERISA note: If your Aetna coverage comes through a large self-funded employer plan, Hawaii’s § 431M-1 state parity statute may not apply directly. Self-funded employer plans are governed by ERISA at the federal level, where the federal MHPAEA still provides meaningful parity protections. Contact your HR department or benefits administrator to determine whether your plan is state-regulated or self-funded.

Hawaii Prepaid Health Care Act and ADHD Coverage

Hawaii’s Prepaid Health Care Act (HRS Chapter 393) is unique among U.S. states — it requires employers to provide health insurance to employees working 20 or more hours per week. This means most Aetna employer-sponsored plans in Hawaii must meet minimum coverage standards set by the Act.

Under HRS § 393, qualifying Aetna plans must include coverage for mental health services. Combined with the § 431M-1 parity requirement, most Hawaii employees with Aetna coverage through their employer may have meaningful access to ADHD evaluation and treatment benefits.

Employees working fewer than 20 hours per week may not be covered under the Prepaid Health Care Act — check with your employer or the Hawaii Department of Labor and Industrial Relations (DLIR) at 1-808-586-8777 for guidance on your coverage eligibility.

What ADHD Services May Aetna Cover in Hawaii?

Subject to plan-specific deductibles, copays, and prior authorization requirements, Aetna Hawaii plans may cover:

• ADHD evaluation and diagnosis — psychiatric or psychological assessment by a licensed provider
• Medication management — ongoing prescribing and follow-up appointments for stimulant and non-stimulant medications
• Cognitive Behavioral Therapy (CBT) — individual or group therapy targeting ADHD-related executive function and behavioral challenges
• Telehealth services — virtual ADHD evaluation and medication management, subject to Aetna telehealth coverage policies
• ADHD coaching and behavioral interventions — coverage varies significantly by plan
• Prescription medications — stimulants and non-stimulants per CVS Caremark formulary (see table above)

How to Verify Your Aetna ADHD Coverage in Hawaii

1. Log in to your Aetna member portal at aetna.com and review your Summary of Benefits and Coverage (SBC) for mental health benefits
2. Call Aetna member services at 1-800-872-3862 — ask specifically about ADHD evaluation coverage, medication benefits, and telehealth
3. Check the CVS Caremark formulary for your specific plan at caremark.com or call 1-800-552-8159
4. Ask your provider to run an eligibility and benefits check before your first appointment — most providers can verify Aetna benefits electronically
5. Contact the Hawaii Insurance Division at 1-808-586-2790 if you believe your plan is not complying with parity requirements

Get ADHD Treatment Through Klarity Health

Klarity Health connects Hawaii residents with 2,000+ licensed providers who offer ADHD evaluation, diagnosis, and medication management via telehealth. Klarity providers are EPCS-compliant and can prescribe Schedule II stimulants electronically in Hawaii where clinically appropriate.

Check If Your Aetna Plan May Cover ADHD Treatment →

Key Contacts

• Aetna Member Services: 1-800-872-3862
• CVS Caremark (pharmacy benefits): 1-800-552-8159
• Aetna Provider Portal / PA: aetna.com (via Availity)
• Hawaii Insurance Division: 1-808-586-2790
• Hawaii Insurance Division website: insurance.hawaii.gov
• Hawaii DLIR (Prepaid Health Care Act): 1-808-586-8777
• SAMHSA National Helpline: 1-800-662-4357
• 988 Suicide & Crisis Lifeline: 988

Frequently Asked Questions

Does Aetna cover Adderall in Hawaii?

Aetna Hawaii plans using the CVS Caremark formulary may cover generic amphetamine salts (Adderall generics) at Tier 1–2, often with lower cost sharing. Brand-name Adderall XR is typically Tier 3–4 and may require prior authorization with step therapy (trial of a generic first). Verify your specific plan’s formulary at aetna.com or call 1-800-872-3862.

Is Vyvanse covered by Aetna in Hawaii?

Generic lisdexamfetamine (the generic equivalent of Vyvanse) is now available and typically placed at Tier 2–3 on CVS Caremark commercial formularies. Brand-name Vyvanse is usually Tier 3–4 with PA and step therapy requirements. Ask your provider to prescribe the generic first if cost is a concern.

Do I need a referral to see an ADHD specialist under Aetna?

Referral requirements depend on your plan type. Aetna HMO plans in Hawaii typically require a referral from your primary care physician to see a psychiatrist or specialist. Aetna PPO and HDHP plans generally do not require a referral for specialist visits. Check your plan documents or call Aetna at 1-800-872-3862 to confirm.

Do ADHD stimulants require electronic prescribing in Hawaii?

Yes. Under HRS § 329-38.5, Schedule II stimulants — including amphetamine salts, methylphenidate, and lisdexamfetamine — must be prescribed electronically in Hawaii. Non-stimulants (atomoxetine, guanfacine ER, clonidine ER, viloxazine) are non-scheduled and are not subject to this requirement.

What if my Aetna PA for an ADHD medication is denied?

You have the right to appeal a PA denial. Your provider can submit a peer-to-peer review request or a formal appeal through Aetna’s appeals process. Contact Aetna member services at 1-800-872-3862 to request an appeal. You may also file a complaint with the Hawaii Insurance Division at 1-808-586-2790 if you believe the denial violates parity requirements.

Does the Hawaii Prepaid Health Care Act guarantee ADHD coverage?

HRS Chapter 393 requires Hawaii employers to provide qualifying health coverage to employees working 20 or more hours per week — but it does not mandate coverage for specific conditions like ADHD. Coverage specifics depend on the Aetna plan your employer has selected, subject to the parity protections of Haw. Rev. Stat. § 431M-1.

Disclaimer: This article is for informational purposes only and does not constitute legal, medical, or insurance advice. Insurance coverage varies significantly by plan, employer, and individual circumstances. Coverage descriptions use qualifying language (“may,” “typically,” “often,” “in many cases”) because actual benefits depend on your specific Aetna plan documents. Always verify your benefits directly with Aetna before scheduling an appointment or filling a prescription. Information is current as of July 2026 and is subject to change.